Close
Back to VSTM Stock Lookup

Verastem Oncology (VSTM) – Major News

Mar 14, 2024 05:43 PM Verastem Oncology (VSTM) Misses Q4 EPS by 102c
Nov 9, 2023 07:52 AM Verastem Oncology (VSTM) Tops Q3 EPS by 8c
Aug 8, 2023 05:32 PM Verastem (VSTM) Misses Q2 EPS by 26c
May 9, 2023 05:43 PM Verastem (VSTM) Misses Q1 EPS by 1c
Mar 14, 2023 04:50 PM Verastem (VSTM) Tops Q4 EPS by 2c
Oct 29, 2019 04:26 PM Verastem (VSTM) Tops Q3 EPS by 11c
Aug 1, 2019 05:26 PM Verastem (VSTM) Misses Q2 EPS by 7c
May 9, 2019 04:47 PM Verastem (VSTM) Misses Q1 EPS by 5c, Revenues Miss; FY19 Revenue Guidance Below Consensus
Mar 12, 2019 04:25 PM Verastem (VSTM) Reports Q4 Loss Per Share of 37c
Sep 24, 2018 03:49 PM Verastem (VSTM) Confirms FDA Approval of COPIKTRA (duvelisib)
Nov 7, 2016 04:12 PM Verastem (VSTM) Tops Q3 EPS by 3c
Aug 8, 2016 08:43 AM Verastem (VSTM) Tops Q2 EPS by 6c
Oct 8, 2015 04:52 PM Verastem (VSTM) Plans 50% Workforce Reduction
Sep 28, 2015 07:01 AM Verastem (VSTM) Ceases VS-6063 Phase 2 Enrollment in Mesothelioma Following DSMB Recommendation
Aug 10, 2015 07:32 AM Verastem (VSTM) Tops Q2 EPS by 3c
May 12, 2015 07:01 AM Verastem (VSTM) Reports Q1 Loss of $0.46/Share
Aug 13, 2013 07:12 AM Verastem Shs (VSTM) Posts Q2 Loss of 49c/Share
Jun 6, 2013 07:09 AM Verastem (VSTM) Promotes Robert Forrester to CEO
May 9, 2013 07:38 AM Verastem Shs (VSTM) Posts Q1 Loss of 44c/Share
Aug 13, 2012 07:01 AM Verastem Shs (VSTM) Reports In-Line Q2 Loss of 34c/Share
Jan 27, 2012 10:49 AM Verastem (VSTM) IPO Trades Higher

Back to VSTM Stock Lookup